RAAS INHIBITORS ARE CARDIOPROTECTIVE IN PATIENTS WITH COVID-19

被引：0
|
作者：
Holmes, Adam R. [1 ]
Nelson, Jacob [1 ]
Hirschl, Jacob [1 ]
Perkins, Sidney J. [1 ]
Chopra, Zoey [1 ]
Fung, Christopher [1 ]
Medlin, Richard P., Jr. [1 ]
Korley, Frederick K. [1 ]
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2021年 / 77卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3073 / 3073
页数：1
相关论文
共 50 条
  • [31] RAAS inhibition and beyond-cardiovascular medications in patients at risk of or affected by COVID-19
    Dutsch, Alexander
    Schunkert, Heribert
    [J]. HERZ, 2023, 48 (03) : 206 - 211
  • [32] COVID-19 and RAAS blockers: Could Aliskiren be an appropriate option?
    Sen, Selcuk
    Uresin, Ali Yagiz
    [J]. TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY, 2020, 48 (07): : 631 - 634
  • [33] Immune checkpoint inhibitors in cancer patients with COVID-19
    Pan, Yun
    Tan, Jiaxiong
    Li, Jinzhong
    Li, Taoyuan
    Li, Jieying
    Cao, Yang
    Yang, Liu
    Lin, Xunge
    Li, Minran
    Liang, Xujing
    [J]. OPEN LIFE SCIENCES, 2023, 18 (01):
  • [34] COVID-19 and the RAAS-a potential role for angiotensin II?
    Busse, Laurence W.
    Chow, Jonathan H.
    McCurdy, Michael T.
    Khanna, Ashish K.
    [J]. CRITICAL CARE, 2020, 24 (01)
  • [35] RAAS, ACE2 and COVID-19; a mechanistic review
    Elshafei, Ahmed
    Khidr, Emad Gamil
    El-Husseiny, Ahmed A.
    Gomaa, Maher H.
    [J]. SAUDI JOURNAL OF BIOLOGICAL SCIENCES, 2021, 28 (11) : 6465 - 6470
  • [36] The Interplay Between the Immune System, the Renin-Angiotensin-Aldosterone System (RAAS), and RAAS Inhibitors May Modulate the Outcome of COVID-19: A Systematic Review
    Naveed, Hiba
    Elshafeey, Abdallah
    Al-Ali, Dana
    Janjua, Emmad
    Nauman, Areej
    Kawas, Hussam
    Kaul, Ridhima
    Saed Aldien, Arwa
    Elshazly, Mohamed B.
    Zakaria, Dalia
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 61 (08): : 987 - 1000
  • [37] Use of RAAS Inhibitors and Risk of Clinical Deterioration in COVID-19: Results From an Italian Cohort of 133 Hypertensives
    Felice, Carla
    Nardin, Chiara
    Di Tanna, Gian Luca
    Grossi, Ugo
    Bernardi, Enrico
    Scaldaferri, Luca
    Romagnoli, Micaela
    Tonon, Luca
    Cavasin, Paola
    Novello, Simone
    Scarpa, Riccardo
    Farnia, Antonio
    De Menis, Ernesto
    Rigoli, Roberto
    Cinetto, Francesco
    Pauletto, Paolo
    Agostini, Carlo
    Rattazzi, Marcello
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 2020, 33 (10) : 944 - 948
  • [38] Calcineurin Inhibitors and COVID-19
    Hage, Rene
    Schuurmans, Mace M.
    [J]. REUMATOLOGIA CLINICA, 2022, 18 (05): : 314 - 315
  • [39] JAK inhibitors and COVID-19
    Levy, Gabriel
    Guglielmelli, Paola
    Langmuir, Peter
    Constantinescu, Stefan
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (04)
  • [40] Polymorphism of RAAS genes in patients with COVID-19: comparison with frequency in population and relationship with severity of course
    Bragina, Anna E.
    Rodionova, Yulia N.
    Ogibenina, Ekaterina S.
    Fomin, Alexander S.
    Podzolkov, Valery I.
    [J]. TERAPEVTICHESKII ARKHIV, 2024, 96 (09): : 872 - 878
12345